What does the ideal medical travel destination look like?


Building an attractive and sustainable destination for medical tourism requires a large amount of trust and a long-term game plan. Sherene Azli, CEO of Malaysia Healthcare Travel Council will be sharing her experience in the ‘Destination Development’ session at the IMTJ Summit in Athens next week.

Over 920,00 healthcare travelers now come to Malaysia for treatment, but this has taken more than seven years of effort from a dedicated public-private partnership between the Malaysian Ministry of Health and private healthcare providers.   Sherene will be talking about how the MHTC, an agency within the Ministry of Health, works with organisations that span the full medical tourism experience, from the minute a patient arrives in Malaysia through to their departure.  She will share her experience of avoiding ‘over commercialisation’ in promoting the sector, and on focusing instead on patient safety and building trust between private providers to deliver quality services.   She will also highlight some of the ongoing challenges in developing Malaysia as a medical travel destination.

In her role at MHTC, Sherene has the task of positioning Malaysia as the “preferred destination for world-class healthcare services”.  She has an instrumental role in promoting global awareness of the Malaysian healthcare industry.

Come and listen to Sherene at the IMTJ Medical Travel Summit – 11.25am, Tuesday 22nd May, Wyndham Grand Hotel, Athens.




Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

Australia’s pan-European bid

15 October, 2018

Australia’s Ramsay Health Care ups bid for Capio AB

Croatia tourism challenge

10 October, 2018

Why hasn’t Croatia’s tourist boom happened?

Germany outbound fertility travel

05 October, 2018

Same-sex German couples forced to travel for treatment

US Mayo expands

01 October, 2018

US$648m development in Arizona, US

Dubai stem cell therapy

27 September, 2018

DHA launches new stem cell therapy